glp-1 drugs covered by medicaid House panel gives drug coverage for adults on a thumbs down More states consider dropping GLP-1

M.KorellM.et al (2011)

Systemic inhibition of EPAC1/2 activity delays melanoma tumor growth in vivo To test the role of EPACs in melanomagenesis, we initiated melanoma development in immunocompetent Braf/Pten ( BPT ) mice by topical application 4HT (4-hydroxytamoxifen) on the shaved flanks

Intended Use: Reconstitution of lyophilized research peptides Laboratory dilutions requiring bacteriostatic conditions Multi-use sterile laboratory applications CJC-1295 No DAC + Ipamorelin 5mg + 5mg (10mg total) CJC-1295 No DAC + Ipamorelin CJC-1295 No DAC + Ipamorelin (Lyophilized Blend) For Research Use Only This synergistic blend of CJC-1295 No DAC and Ipamorelin is designed for advanced research into growth hormone (GH) release dynamics

Ipamorelin is a Growth Hormone Releasing Peptide (GHRP) that also encourages growth hormone release by mimicking ghrelin, a natural hunger hormone, without impacting cortisol or prolactin levels

E.AugustoC.StoltzfusB.Carkaci-SalliN.VranaK

Researchers interested in glow peptides and skin rejuvenation often combine these two compounds for synergistic dermatological benefits